184 related articles for article (PubMed ID: 24113859)
1. Commentary on the abuse of metal chelation therapy in patients with autism spectrum disorders.
Brent J
J Med Toxicol; 2013 Dec; 9(4):370-2. PubMed ID: 24113859
[TBL] [Abstract][Full Text] [Related]
2. Introduction to special issue: use and misuse of metal chelation therapy.
McKay CA
J Med Toxicol; 2013 Dec; 9(4):298-300. PubMed ID: 24248425
[No Abstract] [Full Text] [Related]
3. A biomarker of mercury body-burden correlated with diagnostic domain specific clinical symptoms of autism spectrum disorder.
Kern JK; Geier DA; Adams JB; Geier MR
Biometals; 2010 Dec; 23(6):1043-51. PubMed ID: 20532957
[TBL] [Abstract][Full Text] [Related]
4. Editorial: Use and misuse of metal chelation therapy.
McKay CA
J Med Toxicol; 2013 Dec; 9(4):301-2. PubMed ID: 24178901
[No Abstract] [Full Text] [Related]
5. Recommendations for provoked challenge urine testing.
Ruha AM
J Med Toxicol; 2013 Dec; 9(4):318-25. PubMed ID: 24113861
[TBL] [Abstract][Full Text] [Related]
6. The role of chelation in the treatment of other metal poisonings.
Smith SW
J Med Toxicol; 2013 Dec; 9(4):355-69. PubMed ID: 24113858
[TBL] [Abstract][Full Text] [Related]
7. ALS, mercury exposure, and chelation therapy.
Costa A; Branca V; Pigatto PD; Guzzi G
Clin Neurol Neurosurg; 2008 Mar; 110(3):319-20. PubMed ID: 18054425
[No Abstract] [Full Text] [Related]
8. Current use of chelation in American health care.
Wax PM
J Med Toxicol; 2013 Dec; 9(4):303-7. PubMed ID: 24113860
[TBL] [Abstract][Full Text] [Related]
9. ACMT chelation position adopted by oregon medical board.
Burton BT
J Med Toxicol; 2014 Jun; 10(2):244. PubMed ID: 24558015
[No Abstract] [Full Text] [Related]
10. Public health department response to mercury poisoning: the importance of biomarkers and risks and benefits analysis for chelation therapy.
McKay CA
J Med Toxicol; 2013 Dec; 9(4):308-12. PubMed ID: 24197663
[TBL] [Abstract][Full Text] [Related]
11. Medical toxicology case presentations: to chelate or not to chelate, is that the question?
McKay CA
J Med Toxicol; 2013 Dec; 9(4):373-9. PubMed ID: 24243289
[TBL] [Abstract][Full Text] [Related]
12. The role of chelation in the treatment of arsenic and mercury poisoning.
Kosnett MJ
J Med Toxicol; 2013 Dec; 9(4):347-54. PubMed ID: 24178900
[TBL] [Abstract][Full Text] [Related]
13. An adolescent girl with hypertension and neuropsychiatric symptoms: questions.
Ozçakar ZB; Bolkent MG; Kavaz A; Oztürk BB; Deda G; Ekim M; Yalçınkaya F
Pediatr Nephrol; 2013 Mar; 28(3):427, 429-31. PubMed ID: 22744768
[No Abstract] [Full Text] [Related]
14. The scientific basis for chelation: animal studies and lead chelation.
Smith D; Strupp BJ
J Med Toxicol; 2013 Dec; 9(4):326-38. PubMed ID: 24113857
[TBL] [Abstract][Full Text] [Related]
15. Chelation for autism spectrum disorder (ASD).
James S; Stevenson SW; Silove N; Williams K
Cochrane Database Syst Rev; 2015 May; (5):CD010766. PubMed ID: 26106752
[TBL] [Abstract][Full Text] [Related]
16. The use of chelating agents in occupational lead poisoning.
Porru S; Alessio L
Occup Med (Lond); 1996 Feb; 46(1):41-8. PubMed ID: 8672793
[TBL] [Abstract][Full Text] [Related]
17. Mercury intoxication: lack of correlation between symptoms and levels.
Gattineni J; Weiser S; Becker AM; Baum M
Clin Pediatr (Phila); 2007 Nov; 46(9):844-6. PubMed ID: 17641124
[TBL] [Abstract][Full Text] [Related]
18. Inorganic mercury poisoning associated with skin-lightening cosmetic products.
Chan TY
Clin Toxicol (Phila); 2011 Dec; 49(10):886-91. PubMed ID: 22070559
[TBL] [Abstract][Full Text] [Related]
19. Heavy metal chelation tests: the misleading and hazardous promise.
Hoet P; Haufroid V; Lison D
Arch Toxicol; 2020 Aug; 94(8):2893-2896. PubMed ID: 32676730
[No Abstract] [Full Text] [Related]
20. Lead poisoning prevention, not chelation (commentary).
Henretig F
J Toxicol Clin Toxicol; 2001; 39(7):659-60. PubMed ID: 11778662
[No Abstract] [Full Text] [Related]
[Next] [New Search]
